Literature DB >> 12951344

A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa.

Yang Li1, Takehiko Mima, Yukiko Komori, Yuji Morita, Teruo Kuroda, Tohru Mizushima, Tomofusa Tsuchiya.   

Abstract

OBJECTIVES: Multidrug efflux pumps are thought to be involved in mediating multidrug resistance in Pseudomonas aeruginosa. Here we aim to characterize hitherto uncharacterized multidrug efflux pumps from P. aeruginosa.
MATERIALS AND METHODS: We isolated a mutant, YM442, which showed elevated resistance to several antimicrobial agents from P. aeruginosa YM44 lacking four major multidrug efflux pumps, MexAB, MexCD-OprJ, MexEF-OprN and MexXY. We cloned genes responsible for the resistance from chromosomal DNA of YM442 using YM44 as host.
RESULTS: We designated the genes mexVW. Introduction of a recombinant plasmid pTAJ2 carrying the mexVW into YM44 cells conferred resistance to fluoroquinolones, tetracycline, chloramphenicol, erythromycin, ethidium bromide and acriflavine. Elevated ethidium bromide extrusion was observed with cells of YM442 and of YM44/pTAJ2. An outer membrane protein OprM was able to cooperate with MexVW. Elevated expression of the mexV gene was observed with YM442 compared with YM44.
CONCLUSIONS: MexV (membrane fusion protein)-MexW (RND-type membrane protein)-OprM is a tripartite multidrug efflux pump. It is suggested that other outer membrane component(s) could cooperate with MexVW.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951344     DOI: 10.1093/jac/dkg390

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  38 in total

1.  Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime.

Authors:  Samer A Alyaseen; Kerryl E Piper; Mark S Rouse; James M Steckelberg; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

2.  Expression, purification, crystallization and preliminary X-ray studies of the outer membrane efflux proteins OprM and OprN from Pseudomonas aeruginosa.

Authors:  Isabelle Broutin; Houssain Benabdelhak; Xavier Moreel; Marie-Bernard Lascombe; Dimitri Lerouge; Arnaud Ducruix
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-02-24

3.  Involvement of a novel efflux system in biofilm-specific resistance to antibiotics.

Authors:  Li Zhang; Thien-Fah Mah
Journal:  J Bacteriol       Date:  2008-05-09       Impact factor: 3.490

Review 4.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 5.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

Review 6.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 7.  Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.

Authors:  Lucía Fernández; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Reverse engineering antibiotic sensitivity in a multidrug-resistant Pseudomonas aeruginosa isolate.

Authors:  Julie M Struble; Ryan T Gill
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

9.  Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.

Authors:  Jocelyn K Middlemiss; Keith Poole
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

10.  An H(+)-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa.

Authors:  Gui-Xin He; Teruo Kuroda; Takehiko Mima; Yuji Morita; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.